European countries have doubts about the safety of the Russian and Chinese vaccines, but after the U.S. Pfizer Pharmaceuticals, Britain’s AstraZeneca Pharmaceuticals and U.S. Modena have announced that they will deliver vaccines to the EU in reduced quantities on the grounds of capacity problems, facing the shortage of vaccine supply, German health Minister Jens Spahn said on Jan. 31 that he was open to Russian and Chinese vaccines. Hungary, for its part, approved the Chinese vaccine on the 29th. Hungary will hold national elections next year, and the Orban government is under pressure to restart the economy as soon as possible, so Hungary became the first EU country to approve China’s new crown vaccine, Orban said, adding that because EU vaccine procurement has been progressing very slowly, it is necessary for Hungary to procure other vaccines that have been proven effective.
The German government held a vaccine summit hosted by Chancellor Angela Merkel on Feb. 1 to discuss solutions to the current problem of insufficient supply of Wuhan pneumonia vaccine, which is affecting the progress of vaccination. Faced with a shortage of vaccine supplies in Europe, German Health Minister Jens Spahn said on Jan. 31 that he was open to Russian and Chinese vaccines.
European Union Executive Committee President Ursula von der Leyen also met with pharmaceutical executives from companies that have vaccine contracts with the EU on January 31. Recently, Pfizer, AstraZeneca and Modena have announced that they will reduce the delivery of vaccines to the EU on the grounds of capacity problems, disrupting the vaccination plans of many EU countries. 31 meeting, AstraZeneca said that the company agreed to supply an additional 9 million doses of vaccines in the first quarter.
Ursula von der Leyen, president of the European Union’s executive committee.
Last week the EU and AstraZeneca accused each other of breaching the contract, with the EU expressing dissatisfaction over AstraZeneca’s inability to meet its commitment to deliver 60 percent of the number of vaccine orders to the EU in the first three months of 2021, illustrating the unfair treatment of the EU by AstraZeneca compared with other customers, including the U.K. On the 29th, the EU moved to tighten vaccine export rules, prompting complaints from the U.K.
The shortage of vaccine supply in Europe has caused the German government to leave the distribution of vaccines to the EU to spark controversy. German Health Minister Spann thus said that there are no obstacles to using Russian or Chinese vaccines in the EU, but the key is that this requires formal approval and adoption in accordance with EU law, and that Germany is willing to use vaccines from China and Russia once they have been approved by the European Medicines Agency. He stressed that “as long as the vaccine is safe and effective, it can help in the response to the New Coronavirus (CCP) outbreak, regardless of the country in which it is produced.”
Although Germany is open to vaccines from China and Russia, approval has been slow to come. With the shortage of vaccines, Spann said that if the Russian satellite V vaccine (Sputnik V) and the Chinese national vaccine (Sinopharm) are approved by the EU, they will consider starting to use them and ask both countries to supply them.
While European countries have doubts about the safety of the Russian and Chinese vaccines, Hungary was the first country in the EU to approve the use of the Russian and Chinese vaccines. early January, Hungary also broke with the EU and issued a temporary license to the Russian satellite V vaccine. The EU said that Hungary’s actions in reaching an agreement outside the EU common framework, while not illegal, were inappropriate.
Hungary’s pharmaceutical and Food regulator approved a vaccine developed by Sinopharm Holdings (Sinopharm), a subsidiary of China National Pharmaceutical Group.
Hungary’s pharmaceutical and food regulator approved a vaccine developed by Sinopharm, a subsidiary of China National Pharmaceutical Group, on 29 May, the first Time a Chinese vaccine has been approved in an EU country.
Hungarian Prime Minister Viktor Orban said, “I will choose to receive the Chinese-made vaccine because I trust the Chinese vaccine more than other vaccines.” Hungarian Foreign Minister Siyarto said that the agreement to purchase 5 million doses of the vaccine was officially signed and will be paid for in four months, allowing Hungary to vaccinate a quarter of the country’s population, or 2.5 million people, possibly resulting in an early relaxation of anti-Epidemic restrictions.
Sialto also specifically mentioned that neighboring Serbia has now more than 300,000 people vaccinated against China, including ethnic Hungarians located in the autonomous province of Vojvodina (Vojvodina), so the Hungarians in Hungary are not the first ethnic Hungarians to be vaccinated against China, to reassure the nation about the Chinese vaccine.
Recent Comments